Tina Boville’s Post

CEO at Aralez Bio | Activate Fellow | TR35

1mo

I’m thrilled to announce Aralez Bio’s oversubscribed Series A! With the close of our round we are accelerating commercialization of our platform by establishing commercial scale biomanufacturing and expanding our portfolio of proprietary ncAAs. This is a huge milestone for our company and I can’t wait to take on the next challenge! A big thank you to the amazing Aralez Bio team, without you none of this would be possible. I’d also like to thank our amazing supporters at Spero Ventures (lead investor), Paladin Capital Group, Good Growth Capital, Astia, Heritage Medical Systems, FreeFlow Ventures, Impact Science Ventures, Juniper VC, and Pineapple Group. Check out our website for more information: https://lnkd.in/g_DydYRX

Aralez Bio

3,208 followers

1mo

Breaking: Aralez Bio is announcing the close of our oversubscribed Series A. This investment will be used to further develop Aralez Bio’s unparalleled collection of noncanonical amino acids (ncAAs) and industry-leading manufacturing capabilities. As part of this expansion, Aralez Bio will establish a manufacturing site with tons-per-year production capacity, enabling support for large commercial programs for clients that include top five global pharmaceutical companies. Learn more on our website: https://lnkd.in/g8T6SXDe

50 Comments

Maureen Stancik Boyce, PhD

Managing Partner and co- Founder at Good Growth Capital

1mo

Congrats to the Aralez Bio team. Very proud for Good Growth Capital to be early investors!

3 Reactions

Alita Carbone

Venture Capital Investor at Impact Science Ventures (industrial decarb & sustainability)

1mo

So honored to join you and the team on the journey. Congratulations Tina Boville and Aralez Bio!

4 Reactions

Jennifer Kan, PhD

Investing in biotech startups solving climate change

1mo

We're thrilled to continue to support you all. Congratulations Tina, David and Team Aralez!!

4 Reactions

Sara Eshelman

Partner at Spero Ventures

1mo

Congratulations Tina Boville!! I am so excited to be a part of your journey!

3 Reactions

David Gunn

CDMO Business Development in Pharma and Biotech Industries

1mo

Keep up the awesome work Tina. Congrats.

1 Reaction

James McAllister

Sales Manager, Eastern US - Immunoassay and Peptide Solutions at Gyros Protein Technologies

1mo

Congrats to you and the team, Tina! Great to see!

Sharon Vosmek

CEO, Astia & Managing Partner, Astia Fund. Series A/B Investor, Board Member, Advisor, Speaker, fierce advocate for my portfolio and champion of teams that include women leaders!

1mo

Thank you for allowing us to join your journey! We at Astia could not be more thrilled. #venturecapital

2 Reactions

Gopala Krishnan Kayar Parvastu

SCM pharma expert inOperations,Procurement of APIs Intermediates Strong in sourcing APIs Intermediates from India/china

1mo

Congrats . Way to go

1 Reaction

Martina (Tina) Diekmann

1mo

Congratulations!

2 Reactions

Alborz Mahdavi

Protomer Technologies

1mo

Congratulations!

See more comments

To view or add a comment, sign in

More Relevant Posts

Industry Today - Market Research Reports and PR distribution

1,364 followers
7mo
Report this post
Expanding Horizons: Unveiling the Growth of Global Microbial API Market Overall Study Report 2024-2031 | DSM, CSPC Pharmaceutical Group Limited., KOLON LIFE SCIENCE https://lnkd.in/e925Fb88 #marketanalysis #marketresearch #marketresearchreports #businessintelligence
Like Comment
To view or add a comment, sign in
Abhivandan Nagia

Director at ABNewswire
7mo
Report this post
Benign Prostatic Hyperplasia Market to Observe Impressive Growth during the Forecast Period, assesses DelveInsight | Dongkook Pharmaceutical, Urovant Sciences, Boston Scientific Corporation, GSK, more #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech

Benign Prostatic Hyperplasia Market to Observe Impressive Growth during the Forecast Period, assesses DelveInsight | Dongkook Pharmaceutical, Urovant Sciences, Boston Scientific Corporation, GSK, more | ABNewswire
Like Comment
To view or add a comment, sign in
Vishal Biswas

"B. Pharmacy Graduate | Seeking Opportunities in Pharmaceutical Industry "
3mo
Report this post
Article published in # International journal of pharmaceutical science Topic - "Extraction And Isolation Of Microcrystalline Cellulose From Sugarcane Bagasse And Comparison With Marketed Microcrystalline Cellulose"
Like Comment
To view or add a comment, sign in
Porton Pharma Solutions Ltd.

16,337 followers
5mo
Report this post
Technology-Driven | Porton's Crystallization Team And Genentech Jointly Published Breakthrough Results In 《Pharmaceutical Research》 Recently, the #crystallization team at Porton Pharma Solutions Ltd. and Genentech, Inc. jointly published a paper titled "Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound" in 《Pharmaceutical Research》, the official journal of the American Association of Pharmaceutical Scientists. This journal focuses on publishing new research results in the combined areas of #medicine and #chemistry. Read more here: https://lnkd.in/eadP4a53 Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB Shanming Kuang | Harsh S. Shah, Ph.D. | Baoshu Z. #pharmaceuticalscience #dehydration #API #researchInnovation #pharmceuticalresearch #healthcare
Like Comment
To view or add a comment, sign in
Abhivandan Nagia

Director at ABNewswire
7mo
Report this post
Benign Prostatic Hyperplasia Market to Observe Impressive Growth during the Forecast Period, assesses DelveInsight | Dongkook Pharmaceutical, Urovant Sciences, Boston Scientific Corporation, GSK, more #Business #HealthMedicine #MarketingSales #PharmaceuticalsBiotech

Benign Prostatic Hyperplasia Market to Observe Impressive Growth during the Forecast Period, assesses DelveInsight | Dongkook Pharmaceutical, Urovant Sciences, Boston Scientific Corporation, GSK, more | ABNewswire
Like Comment
To view or add a comment, sign in
Sisi Ding

Xinxiang Runyu Material Co.,Ltd. [email protected]
3mo
Report this post
Runyu Product Show- 302 Cas No.:321921-71-5 MF： C24H39P Abbreviation:cataCXium A Full Name:Butyldi-1-adamantylphosphine Purity: 98% Runyu mainly focus on four parts: 1. Phosphine Ligands： 2. Nucleotide reagents; 3. Intermediates; 4. Pd- Catslyst： Runyu is manufacture with R&D ： ---ISO 9001:2008 Certified ---100% succeed Onsite/online audit since 2017 ---One research center + two large-scale production workshops ---Supply stable and continuously If interested in, welcome to contact with us: E-mail: [email protected] #cataCXium A #drugdiscovery #cro #cdmo #crdmo #CMO #pharmaceutical #pharma #catalyst #lifesciences #biotech #Runyu #API #drugdevelopment #pharmaceuticalindustry #pharmaceutical #pharmaindustry
Like Comment
To view or add a comment, sign in
J-STAR Research, Inc.

4,152 followers
5mo Edited
Report this post
Technology-Driven | Porton's Crystallization Team And Genentech Jointly Published Breakthrough Results In 《Pharmaceutical Research》 Recently, the #crystallization team at Porton Pharma Solutions Ltd. and Genentech, Inc. jointly published a paper titled "Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound" in 《Pharmaceutical Research》, the official journal of the American Association of Pharmaceutical Scientists. This journal focuses on publishing new research results in the combined areas of #medicine and #chemistry. Read more here: https://lnkd.in/eadP4a53 Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB Shanming Kuang | Harsh S. Shah, Ph.D. | Baoshu Z. #pharmaceuticalscience #dehydration #API #researchInnovation #pharmceuticalresearch #healthcare
Like Comment
To view or add a comment, sign in
Porton Pharma Solutions Ltd.

16,337 followers
1w Edited
Report this post
📣 Extra! Extra! Read all about it! Porton Pharma Solutions Ltd. & Porton J-STAR Research, Inc. are excited to share our latest research in collaboration with Genentech Inc., "Phase Transitions Involving Channel Hydrates of a New Pharmaceutical Compound." 🔗 Read the full article: https://rdcu.be/dKLHN Our study explores the critical role of #hydrates as active #pharmaceutical ingredients (APIs) using advanced analytical techniques. We discovered unique phase transition behaviors in a new pharmaceutical compound with three-channel hydrates, revealing both symmetric and asymmetric lattice relaxations. These findings are crucial for ensuring hydrate stability in drug manufacturing and storage, providing valuable insights for future pharmaceutical developments. Dr. Shanming Kuang | Dr. Harsh S. Shah, Ph.D. | Dr. Baoshu Z. #Contact us here! https://lnkd.in/e7zqdNqS Hope your day is packed with positivity. #follow us here https://lnkd.in/d64pQsdB #PharmaceuticalScience #Hydrates #Dehydration #Rehydration #APIs #DrugStability #ResearchInnovation #Pharma #tbt
Like Comment
To view or add a comment, sign in
Gerardo de Eguiluz

General Manager Sanofi, LATAM Sr. Marketing Director in Sanofi and Abbott, Sr. Market Access and BD Director Medix
7mo
Report this post
Bringing quality and affordable solutions to takle the obesity pandemic in Mexico.
Biocon

871,570 followers
7mo

#Biocon has signed a semi-exclusive distribution and supply agreement with Medix, a specialty pharmaceutical company in #Mexico, for the commercialization of its complex, vertically integrated, peptide drug product, Liraglutide (gSaxenda®), used to treat chronic weight management. This is yet another step forward in delivering on our mission to provide access to innovative, high-quality and affordable medicines around the world. Read more: https://bit.ly/3WDdxlb
1 Comment
Like Comment
To view or add a comment, sign in
Sisi Ding

Xinxiang Runyu Material Co.,Ltd. [email protected]
6mo
Report this post
Runyu Product Show- 240 Cas No.: 102690-88-0 MF:C12H22N3O2P Full name: BIS(2-CYANOETHYL)-N,N-DIISOPROPYL PHOSPHORAMIDITE Purity: > 98.6% Runyu mainly focus on four parts: 1. Phosphine Ligands： 2. Nucleotide reagents; 3. Intermediates; 4. Pd- Catslyst： Runyu is manufacture with R&D ： ---ISO 9001:2008 Certified ---100% succeed Onsite/online audit since 2017 ---One research center + two large-scale production workshops ---Supply stable and continuously #Nucleotidereagents #PhosReagents #Oligonucleotide #Phosphinereagent #drugdiscovery #cro #cdmo #crdmo #pharmaceutical #pharma #catalyst #lifesciences #biotech #Runyu #API #drugdevelopment #pharmaceuticalindustry #pharmaceutical #pharmaindustry
Like Comment
To view or add a comment, sign in

1,769 followers

89 Posts

View Profile Follow

Tina Boville’s Post

More Relevant Posts

Explore topics